HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marc Cohen Selected Research

Non-ST Elevated Myocardial Infarction

2/2020Contemporary NSTEMI management: the role of the hospitalist.
11/2017Timing of Angiography and Outcomes in High-Risk Patients With Non-ST-Segment-Elevation Myocardial Infarction Managed Invasively: Insights From the TAO Trial (Treatment of Acute Coronary Syndrome With Otamixaban).
4/2016Long-term outcomes in high-risk patients with non-ST-segment elevation myocardial infarction.
1/2009Re-evaluating risk factors for periprocedural complications during percutaneous coronary intervention in patients with unstable angina/non-ST-elevation myocardial infarction: who may benefit from more intensive antiplatelet therapy?
2/2003The role of low-molecular-weight heparin in the management of acute coronary syndromes.
9/2002Randomized double-blind safety study of enoxaparin versus unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes treated with tirofiban and aspirin: the ACUTE II study. The Antithrombotic Combination Using Tirofiban and Enoxaparin.
6/2002Identification of patients at high risk for death and cardiac ischemic events after hospital discharge.
1/2002Mode and timing of treatment failure (recurrent ischemic events) after hospital admission for non-ST segment elevation acute coronary syndromes.
1/2002Combination of low molecular weight heparins with antiplatelet agents in non-ST elevation acute coronary syndromes: an update.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marc Cohen Research Topics

Disease

74Hemorrhage
12/2022 - 09/2002
71Myocardial Infarction
11/2023 - 05/2002
56Acute Coronary Syndrome
03/2021 - 01/2002
32ST Elevation Myocardial Infarction
03/2021 - 01/2002
26Stroke (Strokes)
01/2023 - 11/2005
20Thrombosis (Thrombus)
10/2020 - 10/2002
16Atrial Fibrillation
01/2023 - 06/2006
11Neoplasms (Cancer)
02/2024 - 03/2006
11Unstable Angina
02/2020 - 01/2002
10Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 01/2002
9Non-ST Elevated Myocardial Infarction
02/2020 - 01/2002
8Ischemia
04/2019 - 01/2002
8Coronary Disease (Coronary Heart Disease)
09/2016 - 05/2004
7Pain (Aches)
12/2022 - 03/2003
7Heart Failure
10/2020 - 03/2008
7Coronary Artery Disease (Coronary Atherosclerosis)
02/2020 - 05/2004
7Infarction (Infarctions)
01/2019 - 01/2002
6Hypertension (High Blood Pressure)
01/2021 - 05/2011
5Cardiogenic Shock
01/2019 - 10/2002
4COVID-19
12/2021 - 01/2020
4Diabetes Mellitus
01/2021 - 05/2003
4Peripheral Arterial Disease
01/2020 - 04/2016
3Pituitary Neoplasms (Pituitary Adenoma)
01/2022 - 10/2018
3Aortic Valve Stenosis (Aortic Stenosis)
01/2022 - 06/2017
3Thromboembolism
12/2021 - 06/2006
3Venous Thromboembolism
12/2021 - 05/2011
3Infertility (Sterility)
09/2021 - 07/2014
3Head and Neck Neoplasms (Head and Neck Cancer)
01/2019 - 04/2010
3Intracranial Hemorrhages (Intracranial Hemorrhage)
12/2018 - 01/2012
3Ischemic Stroke
09/2016 - 05/2004
3Common Cold
11/2014 - 07/2009
2Inflammation (Inflammations)
12/2022 - 03/2006
2Sepsis (Septicemia)
12/2021 - 12/2021
2Anemia
01/2021 - 07/2002
2Hypertrophy
01/2021 - 01/2021
2Squamous Cell Carcinoma of Head and Neck
01/2021 - 11/2018
2Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
12/2020 - 01/2016
2Heart Arrest (Cardiac Arrest)
11/2020 - 10/2015

Drug/Important Bio-Agent (IBA)

45Heparin (Liquaemin)FDA LinkGeneric
11/2023 - 01/2002
42Enoxaparin (Lovenox)FDA LinkGeneric
01/2017 - 01/2002
23Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
12/2022 - 09/2002
20TicagrelorIBA
12/2022 - 04/2014
19AnticoagulantsIBA
11/2019 - 01/2002
14Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
12/2021 - 01/2002
13RivaroxabanIBA
11/2019 - 10/2010
12Vitamin KFDA Link
11/2019 - 06/2006
102'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
05/2020 - 07/2013
9omega-Chloroacetophenone (Mace)IBA
01/2021 - 10/2008
9Glycoproteins (Glycoprotein)IBA
01/2018 - 10/2002
8Eptifibatide (Integrilin)FDA Link
03/2021 - 01/2002
8otamixabanIBA
03/2021 - 05/2007
7Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
01/2018 - 01/2002
7Tirofiban (Aggrastat)FDA Link
06/2005 - 01/2002
6Biomarkers (Surrogate Marker)IBA
12/2022 - 01/2020
6Clopidogrel (Plavix)FDA Link
02/2020 - 10/2010
6Warfarin (Coumadin)FDA LinkGeneric
11/2019 - 05/2004
6AntithrombinsIBA
07/2011 - 07/2004
5Troleandomycin (TAO)FDA Link
03/2021 - 09/2013
4Oxygen (Dioxygen)IBA
12/2021 - 11/2014
4Factor Xa (Coagulation Factor Xa)IBA
01/2021 - 05/2007
4TroponinIBA
11/2020 - 08/2017
4Hemoglobins (Hemoglobin)IBA
10/2020 - 01/2003
4Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2020 - 12/2006
4Antiviral Agents (Antivirals)IBA
11/2014 - 07/2009
3CollagenIBA
09/2022 - 01/2009
3HomocysteineIBA
09/2021 - 12/2011
3CreatinineIBA
10/2020 - 03/2008
3ThrombinFDA Link
12/2018 - 12/2009
3Purinergic P2Y Receptor AntagonistsIBA
05/2015 - 12/2009
3Factor Xa InhibitorsIBA
10/2014 - 10/2008
3Fibrinolytic Agents (Antithrombotic Agents)IBA
08/2012 - 01/2004
3Platelet Membrane Glycoprotein IIbIBA
10/2003 - 01/2002
2bivalirudin (Angiomax)FDA Link
11/2023 - 10/2008
2Folic Acid (Vitamin M)FDA LinkGeneric
10/2022 - 01/2020
2AcidsIBA
12/2021 - 10/2020
2fibrin fragment D (D-dimer)IBA
12/2021 - 12/2021
2Alkylating AgentsIBA
10/2021 - 10/2018
2NivolumabIBA
10/2021 - 10/2018
2Temozolomide (Temodar)FDA LinkGeneric
10/2021 - 10/2018
2IpilimumabIBA
10/2021 - 10/2018
2saxagliptinFDA Link
01/2021 - 01/2021
2CholesterolIBA
11/2020 - 01/2009

Therapy/Procedure

65Therapeutics
05/2024 - 01/2002
49Percutaneous Coronary Intervention
03/2021 - 01/2002
12Coronary Artery Bypass (Coronary Artery Bypass Surgery)
02/2020 - 10/2003
10Stents
10/2020 - 07/2013
8Transcatheter Aortic Valve Replacement
01/2022 - 01/2016
7Patient Readmission
02/2020 - 09/2002
7Counterpulsation (External Counterpulsation)
01/2019 - 10/2002
4Length of Stay
01/2022 - 12/2016
4Radiotherapy
01/2019 - 04/2010
4Secondary Prevention
12/2018 - 05/2004
4Drug Therapy (Chemotherapy)
10/2018 - 05/2009
3Contraindications
01/2023 - 05/2010
3Vascular Closure Devices
09/2022 - 01/2003
3Blood Transfusion (Blood Transfusions)
06/2013 - 01/2003
2Phototherapy (Light Therapy)
04/2022 - 01/2022
2Free Tissue Flaps
01/2022 - 04/2010
2Immunotherapy
10/2021 - 10/2018
2Extracorporeal Membrane Oxygenation
11/2020 - 01/2016